Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Review (5 RCTs, n=1719) found moderate‐certainty evidence of little/no difference in primary survival outcomes between primary debulking surgery and neoadjuvant chemotherapy, but latter may reduce risk of serious adverse events and need for bowel resection and stoma formation.


Cochrane Database of Systematic Reviews